Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02713230 · ClinicalTrials.gov registry record · Phase 3
Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery
A Phase 3 study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 156
- Enrollment target
NCT02713230 is a Phase 3 study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 156 participants.
The verdict
NCT02713230, a Phase 3 study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 156 participants
- Enrollment target
Study Summary
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study in 155 adult subjects undergoing primary unilateral total shoulder arthroplasty or rotator cuff repair with general anesthesia
Interventions
- DRUG Placebo
- DRUG bupivacaine liposome injectable suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2016-05-09 |
| Est. Completion | 2017-07-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02713230
The ClinicalTrials.gov registry entry for NCT02713230 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02713230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02713230 about?
NCT02713230 is a clinical study titled "Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery". This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study in 155 adult subjects undergoing primary unilateral total shoulder arthroplasty or rotator cuff repair with general anesthesia
What is the current status of trial NCT02713230?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 156 participants. The study started on 2016-05-09. Estimated completion is 2017-07-07.
What interventions are being tested in trial NCT02713230?
The interventions under investigation include: Placebo (DRUG), bupivacaine liposome injectable suspension (DRUG).
Who is sponsoring clinical trial NCT02713230?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.